NURIX THERAPEUTICS INC (NRIX) Institutional Ownership Changes & 13F Activity
NURIX THERAPEUTICS INC (NRIX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Rubric Capital Management Lp, Redmile Group, Llc, Price T Rowe Associates Inc, Vestal Point Capital, Lp, and Deep Track Capital, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -10,320 | -5.8% | 168,857 | $4.10M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +133,319 | +9.9% | 1,477,019 | $35.83M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -29,715 | -30.0% | 69,327 | $1.68M | Q2 2026 | Aug 24, 2026 |
| Mercer Global Advisors Inc | Buy | +12,035 | — | 12,035 | $291.97K | Q2 2026 | Aug 19, 2026 |
| Rubric Capital Management Lp | Buy | +4,753,893 | +192.2% | 7,227,778 | $175.35M | Q2 2026 | Aug 14, 2026 |
| Redmile Group, Llc | Sell | -3,659,021 | -47.3% | 4,073,787 | $98.83M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +2,146,354 | +65.2% | 5,436,587 | $131.89M | Q2 2026 | Aug 14, 2026 |
| Vestal Point Capital, Lp | Buy | +1,550,000 | +23.8% | 8,050,000 | $195.29M | Q2 2026 | Aug 14, 2026 |
| Deep Track Capital, Lp | Buy | +1,391,211 | +21.9% | 7,736,455 | $187.69M | Q2 2026 | Aug 14, 2026 |
| General Atlantic, L.P. | Sell | -1,069,680 | -26.1% | 3,032,185 | $73.56M | Q2 2026 | Aug 14, 2026 |
| Perceptive Advisors Llc | Buy | +609,545 | +16.4% | 4,320,422 | $104.81M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -525,387 | -96.2% | 20,910 | $507.28K | Q2 2026 | Aug 14, 2026 |
| Sofinnova Investments, Inc. | Buy | +524,098 | — | 524,098 | $12.71M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -505,070 | -38.3% | 813,589 | $19.74M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Sell | -463,997 | -26.5% | 1,286,769 | $31.22M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Sell | -376,455 | -77.6% | 108,757 | $2.64M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Sell | -376,037 | -83.7% | 73,069 | $1.77M | Q2 2026 | Aug 14, 2026 |
| Ecor1 Capital, Llc | Buy | +270,000 | — | 270,000 | $6.55M | Q2 2026 | Aug 14, 2026 |
| Jacobs Levy Equity Management, Inc | Sell | -257,217 | -41.4% | 363,603 | $8.82M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +257,166 | +458.7% | 313,236 | $7.60M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Sell | -192,049 | -91.6% | 17,645 | $428.07K | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +178,049 | — | 178,049 | $4.32M | Q2 2026 | Aug 14, 2026 |
| Trails Edge Capital Partners, Lp | Sell | -170,000 | -9.8% | 1,573,220 | $38.17M | Q2 2026 | Aug 14, 2026 |
| Kennedy Capital Management Llc | Buy | +163,258 | +29.1% | 724,508 | $17.58M | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +163,058 | +993.9% | 179,464 | $4.35M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Sell | -159,652 | -46.4% | 184,551 | $4.48M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Buy | +138,562 | +15.0% | 1,064,006 | $25.81M | Q2 2026 | Aug 14, 2026 |
| Alyeska Investment Group, L.P. | Buy | +138,122 | — | 138,122 | $3.35M | Q2 2026 | Aug 14, 2026 |
| Susquehanna Portfolio Strategies, Llc | Buy | +125,261 | +116.3% | 232,924 | $5.65M | Q2 2026 | Aug 14, 2026 |
| Raymond James Financial Inc | Buy | +121,782 | +66.3% | 305,384 | $7.41M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about NRIX activity
Which institutional owners are buying NRIX?
Institutional owners buying NRIX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in NRIX activity?
"Buy" means an investor increased their reported position in NRIX compared to the prior reporting period. This reflects growing exposure to NURIX THERAPEUTICS INC (NRIX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in NRIX increasing?
Institutional interest in NRIX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related NRIX Institutional Insights
- NRIX Overview
- NRIX 13F Institutional Holders
- NRIX Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- NRIX Insider Trading & SEC Form 4 Activity
- NRIX Articles
- Top Institutional Investor Stock Rankings